S
Sarepta Therapeutics, Inc.
SRPT · NASDAQ · Healthcare · 1.9B
Price · close
$18.79
-2.24% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
1.7×
Enterprise value / EBITDAEV/EBITDA
-3.4×
Free cash flow yieldFCF yield
-15.6%
Return on equityROE
-62.5%
Operating margin
-29.9%
Net debt / EBITDAbalance-sheet strength
-0.4×
Interest coverage
-67.6×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.